Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 12, Pages e29290
Publisher
Public Library of Science (PLoS)
Online
2011-12-17
DOI
10.1371/journal.pone.0029290
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Frizzled-7 as a Potential Therapeutic Target in Colorectal Cancer
- (2015) Koji Ueno et al. NEOPLASIA
- Antihelminth Compound Niclosamide Downregulates Wnt Signaling and Elicits Antitumor Responses in Tumors with Activating APC Mutations
- (2011) T. Osada et al. CANCER RESEARCH
- Mesd is a general inhibitor of different Wnt ligands in Wnt/LRP signaling and inhibits PC-3 tumor growth in vivo
- (2011) Cuihong Lin et al. FEBS LETTERS
- Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer
- (2011) U. Sack et al. JNCI-Journal of the National Cancer Institute
- FZD7 has a critical role in cell proliferation in triple negative breast cancer
- (2011) L Yang et al. ONCOGENE
- Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells
- (2011) Desheng Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wnt/β-catenin Signaling in Normal and Cancer Stem Cells
- (2011) Kenneth C. Valkenburg et al. Cancers
- Mesd Is a Universal Inhibitor of Wnt Coreceptors LRP5 and LRP6 and Blocks Wnt/β-Catenin Signaling in Cancer Cells
- (2010) Wenyan Lu et al. BIOCHEMISTRY
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Wnt Isoform-Specific Interactions with Coreceptor Specify Inhibition or Potentiation of Signaling by LRP6 Antibodies
- (2010) Yan Gong et al. PLoS One
- Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies
- (2010) S. A. Ettenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy
- (2010) C.-C. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wnt signaling in stem and cancer stem cells
- (2010) Peter Wend et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- The Anti-Helminthic Niclosamide Inhibits Wnt/Frizzled1 Signaling
- (2009) Minyong Chen et al. BIOCHEMISTRY
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
- (2009) Bryan T. MacDonald et al. DEVELOPMENTAL CELL
- Wnt signaling activation and mammary gland hyperplasia in MMTV–LRP6 transgenic mice: implication for breast cancer tumorigenesis
- (2009) J Zhang et al. ONCOGENE
- The Wnt Co-Receptor Lrp6 Is Required for Normal Mouse Mammary Gland Development
- (2009) Charlotta Lindvall et al. PLoS One
- In vitro trypanocidal activity of the anti-helminthic drug niclosamide
- (2008) Karin Merschjohann et al. EXPERIMENTAL PARASITOLOGY
- R-spondin1 synergizes with Wnt3A in inducing osteoblast differentiation and osteoprotegerin expression
- (2008) Wenyan Lu et al. FEBS LETTERS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started